India's Covaxin Shot 78% Effective Against Coronavirus, Say Developers

India's Covaxin Shot 78% Effective Against Coronavirus, Say Developers

April 22, 2021, 7:20 a.m.

India's only domestically developed COVID-19 vaccine, Covaxin, has been found to be 78% effective in a second analysis of clinical trials done around the country, its makers said here on Wednesday.

“I am very pleased to state that Covaxin ... has shown the efficacy of 78% in the second interim analysis,” said Balram Bhargava, the chief of the state-run Indian Council of Medical Research that has created the vaccine with Bharat Biotech.

The first analysis released in March had shown an efficacy rate of 81%.

More on Health

The Latest

Latest Magazine

VOL. 17, No. 20, May.24,2024 (Jestha-11. 2081) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 17, No. 19, May.10,2024 (Baishak,28. 2081) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 17, No. 18, April.26,2024 (Baishak,14. 2081) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 17, No. 17, April.12,2024 (Chaitra,30. 2080) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75